Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-11

FDA Approved: COLESEVELAM HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's supplemental ANDA for Colesevelam Hydrochloride, allowing the marketing of a generic Colesevelam Hydrochloride product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Welchol (colesevelam hydrochloride) (colesevelam hydrochloride)

Snippet

SUPPL AP for COLESEVELAM HYDROCHLORIDE (COLESEVELAM HYDROCHLORIDE)